Novel Genetic Loci ID'd for Hypertension in European Ancestry
By Elana Gotkine HealthDay Reporter
TUESDAY, May 7, 2024 -- A total of 113 novel genetic loci have been identified in the largest single-stage common variant genome-wide association study of blood pressure (BP) reported to date, according to a study published online April 30 in Nature Genetics.
Jacob M. Keaton, Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined loci in the largest single-stage BP genome-wide association study to date, including 1,028,980 European individuals.
The researchers identified 113 novel loci and reported 2,103 independent genetic signals. These associations accounted for more than 60 percent of single nucleotide polymorphism-based BP heritability. In an independent dataset, clinically meaningful differences in BP were seen when comparing top versus bottom deciles of polygenic risk scores (16.9 mm Hg systolic BP), and the odds of hypertension were significantly increased (odds ratio, 7.33). The area under the receiver operating characteristic curve increased from 0.791 to 0.826 with the addition of the polygenic risk score into hypertension-prediction models. Comparing the 2,103 loci results in non-European ancestries showed significant polygenic risk score associations in a large sample of African American individuals. In secondary analyses, 500 genes previously unreported for BP were implicated.
"Our study results suggest that efforts should continue for future BP-genome-wide associated studies to leverage large-scale biobank resources and cohort studies to expand the sample size further, as well as extending to diverse ancestries," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
High Level of Approval Observed for Polygenic Embryo Screening
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...
Andexanet Yields Better Control of Hematoma Expansion Than Usual Care
FRIDAY, May 17, 2024 -- For patients who had taken factor Xa inhibitors within 15 hours before having an acute intracerebral hemorrhage, andexanet alfa, which reverses the effects...
AI Chatbots Can Generate Quality, Empathetic, Readable Responses
FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.